Back to search

Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression

Data up to Jan 2025

Published2001
Citations98
References24

Total Citations Per Year

Abstract

References (24)

“Mini-mental state”

1975 • 82,784 citations

The Global Deterioration Scale for assessment of primary degenerative dementia

1982 • 4,700 citations

A new rating scale for Alzheimer's disease

1984 • 3,948 citations

A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease

1998 • 473 citations

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

1993 • 422 citations

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration

1994 • 401 citations

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

1992 • 317 citations

Chapter 53: Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease

1993 • 302 citations

Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study

1996 • 209 citations

Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's Disease

1990 • 207 citations

Incidence of Dementia in a Population Older Than 75 Years in the United Kingdom

1994 • 199 citations

Measurement of quality-of-life changes in patients with Alzheimer's disease.

1989 • 186 citations

The Prognosis in Alzheimer's Disease

1990 • 154 citations

Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease

1998 • 148 citations

Extrapyramidal Signs in Patients With Probable Alzheimer Disease

1997 • 121 citations

Molecular Genetics of Alzheimer's Disease

1993 • 99 citations

Natural history of Alzheimer's disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project

1998 • 99 citations

Differential Neuropsychiatric Symptom Responses to Tacrine in Alzheimer's Disease

1998 • 70 citations

'How Far' vs 'How Fast' in Alzheimer's Disease

1994 • 65 citations

Development of aphasia, apraxia, and agnosia and decline in Alzheimer's disease

1993 • 65 citations

Rate of Progression of Alzheimer's Disease Is Associated With Genetic Risk

1995 • 28 citations

Assessment of progression and prognosis in ?possible? and ?probable? Alzheimer's disease

1998 • 13 citations

The effects of tacrine in patients with mild versus moderate stage alzheimer's disease

1994 • 11 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the… (2001) – Archives of Neurology | Metascience Observatory Explorer